Case report: Cutaneous metastasis of squamous cervical carcinoma: complete regression after molecular diagnosis

Common metastasis sites for cervical cancer are the lungs, bones, liver, brain, ovaries, and lymph nodes, among other sites. Skin metastasis is very uncommon, and is only observed in approximately 1% of patients. The cancer spreads typically through lymphatic or blood vessels, but a definitive examp...

Full description

Saved in:
Bibliographic Details
Main Authors: Liwen Guo, Yanqiong Liu, Shuhua Zhang, Wei Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1528957/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593741962018816
author Liwen Guo
Yanqiong Liu
Shuhua Zhang
Wei Liu
Wei Liu
author_facet Liwen Guo
Yanqiong Liu
Shuhua Zhang
Wei Liu
Wei Liu
author_sort Liwen Guo
collection DOAJ
description Common metastasis sites for cervical cancer are the lungs, bones, liver, brain, ovaries, and lymph nodes, among other sites. Skin metastasis is very uncommon, and is only observed in approximately 1% of patients. The cancer spreads typically through lymphatic or blood vessels, but a definitive example of lymphatic spread has not been documented thoroughly in the existing literature. Cutaneous metastasis may be confused with cellulitis or a rash; hence, an immediate cutaneous biopsy of any suspicious lesions is recommended. There is no consensus regarding the treatment of this condition. Only one documented case has shown that a combination of paclitaxel, carboplatin, bevacizumab, and zoledronic acid can lead to a complete metabolic response. Our study, which used two cycles of albumin-bound paclitaxel, cisplatin, and bevacizumab, followed by four cycles of the same regimen plus terprelimab for metastases with CPS scores of Programmed death-ligand 1 (PD-L1) over 10, resulted in a stable complete response for over eight months. Our contribution may assist in formulating effective treatment guidelines for the cutaneous metastasis of squamous cervical carcinoma in the future.
format Article
id doaj-art-cd92a3f795034943a17cb9f231d6b4e4
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-cd92a3f795034943a17cb9f231d6b4e42025-01-20T09:40:18ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.15289571528957Case report: Cutaneous metastasis of squamous cervical carcinoma: complete regression after molecular diagnosisLiwen Guo0Yanqiong Liu1Shuhua Zhang2Wei Liu3Wei Liu4Hunan Cancer Hospital, The Affiliated Cancer Hospital of the Xiangya School of Medicine, Central South University, Changsha, ChinaHunan Cancer Hospital, The Affiliated Cancer Hospital of the Xiangya School of Medicine, Central South University, Changsha, ChinaThird Xiangya Hospital, Central South University, Changsha, ChinaHunan Cancer Hospital, The Affiliated Cancer Hospital of the Xiangya School of Medicine, Central South University, Changsha, ChinaPostdoctor of Pathology of Second Xiangya Hospital, Changsha, China; Honored Professor of Pathology of Shaodong People’s Hospital, Shaodong, Hunan ProvinceCommon metastasis sites for cervical cancer are the lungs, bones, liver, brain, ovaries, and lymph nodes, among other sites. Skin metastasis is very uncommon, and is only observed in approximately 1% of patients. The cancer spreads typically through lymphatic or blood vessels, but a definitive example of lymphatic spread has not been documented thoroughly in the existing literature. Cutaneous metastasis may be confused with cellulitis or a rash; hence, an immediate cutaneous biopsy of any suspicious lesions is recommended. There is no consensus regarding the treatment of this condition. Only one documented case has shown that a combination of paclitaxel, carboplatin, bevacizumab, and zoledronic acid can lead to a complete metabolic response. Our study, which used two cycles of albumin-bound paclitaxel, cisplatin, and bevacizumab, followed by four cycles of the same regimen plus terprelimab for metastases with CPS scores of Programmed death-ligand 1 (PD-L1) over 10, resulted in a stable complete response for over eight months. Our contribution may assist in formulating effective treatment guidelines for the cutaneous metastasis of squamous cervical carcinoma in the future.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1528957/fullcutaneous metastasiscervical carcinomaprognosiscomplete responseimmunochemotherapymolecular diagnosis
spellingShingle Liwen Guo
Yanqiong Liu
Shuhua Zhang
Wei Liu
Wei Liu
Case report: Cutaneous metastasis of squamous cervical carcinoma: complete regression after molecular diagnosis
Frontiers in Immunology
cutaneous metastasis
cervical carcinoma
prognosis
complete response
immunochemotherapy
molecular diagnosis
title Case report: Cutaneous metastasis of squamous cervical carcinoma: complete regression after molecular diagnosis
title_full Case report: Cutaneous metastasis of squamous cervical carcinoma: complete regression after molecular diagnosis
title_fullStr Case report: Cutaneous metastasis of squamous cervical carcinoma: complete regression after molecular diagnosis
title_full_unstemmed Case report: Cutaneous metastasis of squamous cervical carcinoma: complete regression after molecular diagnosis
title_short Case report: Cutaneous metastasis of squamous cervical carcinoma: complete regression after molecular diagnosis
title_sort case report cutaneous metastasis of squamous cervical carcinoma complete regression after molecular diagnosis
topic cutaneous metastasis
cervical carcinoma
prognosis
complete response
immunochemotherapy
molecular diagnosis
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1528957/full
work_keys_str_mv AT liwenguo casereportcutaneousmetastasisofsquamouscervicalcarcinomacompleteregressionaftermoleculardiagnosis
AT yanqiongliu casereportcutaneousmetastasisofsquamouscervicalcarcinomacompleteregressionaftermoleculardiagnosis
AT shuhuazhang casereportcutaneousmetastasisofsquamouscervicalcarcinomacompleteregressionaftermoleculardiagnosis
AT weiliu casereportcutaneousmetastasisofsquamouscervicalcarcinomacompleteregressionaftermoleculardiagnosis
AT weiliu casereportcutaneousmetastasisofsquamouscervicalcarcinomacompleteregressionaftermoleculardiagnosis